| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Acute myeloid leukemia 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 2 | Adipocytokine signaling pathway 3 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 3 | Adrenergic signaling in cardiomyocytes 2 genes, 1 drug (DrugBank), 5 diseases shown |
[2] ADRB1, ADRB2 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| 4 | Alanine, aspartate and glutamate metabolism 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ABAT |
D00535 |
Vigabatrin |
[2] 145, 158 |
| 5 | Alzheimer disease 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 6 | Amphetamine addiction 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 7 | AMPK signaling pathway 4 genes, 4 drugs (DrugBank), 53 diseases shown |
[1] HMGCR |
D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 8 | Amyotrophic lateral sclerosis (ALS) 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 9 | Apelin signaling pathway 3 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 10 | Arachidonic acid metabolism 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] PTGS1, PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 11 | Autophagy - animal 3 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 12 | Autophagy - other 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 13 | Axon guidance 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 14 | B cell receptor signaling pathway 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 15 | beta-Alanine metabolism 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ABAT |
D00535 |
Vigabatrin |
[2] 145, 158 |
| 16 | Bile secretion 1 gene, 1 drug (DrugBank), 19 diseases shown |
[1] HMGCR |
D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| 17 | Breast cancer 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 18 | Butanoate metabolism 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ABAT |
D00535 |
Vigabatrin |
[2] 145, 158 |
| 19 | C-type lectin receptor signaling pathway 6 genes, 2 drugs (DrugBank), 33 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 20 | Calcium signaling pathway 8 genes, 2 drugs (DrugBank), 34 diseases shown |
[3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 21 | cAMP signaling pathway 2 genes, 1 drug (DrugBank), 5 diseases shown |
[2] ADRB1, ADRB2 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| 22 | Cellular senescence 6 genes, 3 drugs (DrugBank), 49 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 23 | Central carbon metabolism in cancer 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 24 | cGMP-PKG signaling pathway 8 genes, 2 drugs (DrugBank), 34 diseases shown |
[3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 25 | Chemical carcinogenesis 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 26 | Choline metabolism in cancer 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 27 | Circadian rhythm 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 28 | Colorectal cancer 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 29 | Dilated cardiomyopathy (DCM) 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] ADRB1 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| 30 | Dopaminergic synapse 3 genes, 1 drug (DrugBank), 30 diseases shown |
[3] PPP3CA, PPP3CB, PPP3CC |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 31 | EGFR tyrosine kinase inhibitor resistance 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 32 | Endocrine and other factor-regulated calcium reabsorption 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] VDR |
D00129 |
Calcitriol |
[8] 37, 46, 49, 66, 96, 158, 235, 326 |
| 33 | Endocrine resistance 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 34 | ErbB signaling pathway 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 35 | Fluid shear stress and atherosclerosis 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 36 | FoxO signaling pathway 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 37 | GABAergic synapse 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ABAT |
D00535 |
Vigabatrin |
[2] 145, 158 |
| 38 | Gap junction 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] ADRB1 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| 39 | Gastric cancer 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 40 | Glioma 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 41 | Glucagon signaling pathway 7 genes, 2 drugs (DrugBank), 40 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 42 | Glutamatergic synapse 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 43 | Growth hormone synthesis, secretion and action 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 44 | Hepatocellular carcinoma 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 45 | Herpes simplex virus 1 infection 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 46 | HIF-1 signaling pathway 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 47 | Human cytomegalovirus infection 7 genes, 4 drugs (DrugBank), 51 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 48 | Human immunodeficiency virus 1 infection 6 genes, 3 drugs (DrugBank), 49 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 49 | Human papillomavirus infection 2 genes, 3 drugs (DrugBank), 40 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 50 | Human T-cell leukemia virus 1 infection 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 51 | Hypertrophic cardiomyopathy (HCM) 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 52 | IL-17 signaling pathway 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 53 | Insulin resistance 3 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 54 | Insulin signaling pathway 3 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 55 | JAK-STAT signaling pathway 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 56 | Kaposi sarcoma-associated herpesvirus infection 7 genes, 4 drugs (DrugBank), 51 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 57 | Leishmaniasis 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 58 | Long-term potentiation 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 59 | Longevity regulating pathway 3 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 60 | Longevity regulating pathway - multiple species 3 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 61 | MAPK signaling pathway 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 62 | Metabolic pathways 4 genes, 3 drugs (DrugBank), 23 diseases shown |
[1] ABAT |
D00535 |
Vigabatrin |
[2] 145, 158 |
| [1] HMGCR |
D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| [2] PTGS1, PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 63 | MicroRNAs in cancer 2 genes, 3 drugs (DrugBank), 40 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 64 | Mineral absorption 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] VDR |
D00129 |
Calcitriol |
[8] 37, 46, 49, 66, 96, 158, 235, 326 |
| 65 | mTOR signaling pathway 3 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 66 | Natural killer cell mediated cytotoxicity 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 67 | Neuroactive ligand-receptor interaction 5 genes, 2 drugs (DrugBank), 17 diseases shown |
[3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| [2] CNR1, CNR2 |
D10915 |
Cannabidiol |
[14] 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
| 68 | NF-kappa B signaling pathway 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 69 | Non-alcoholic fatty liver disease (NAFLD) 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 70 | Oocyte meiosis 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 71 | Osteoclast differentiation 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 72 | Ovarian steroidogenesis 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 73 | Oxytocin signaling pathway 8 genes, 3 drugs (DrugBank), 43 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| [1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 74 | Pancreatic cancer 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 75 | Pancreatic secretion 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SLC12A2 |
D00247 |
Bumetanide |
[2] 6, 158 |
| 76 | Parathyroid hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] VDR |
D00129 |
Calcitriol |
[8] 37, 46, 49, 66, 96, 158, 235, 326 |
| 77 | Pathways in cancer 2 genes, 3 drugs (DrugBank), 40 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 78 | PD-L1 expression and PD-1 checkpoint pathway in cancer 6 genes, 3 drugs (DrugBank), 49 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 79 | Phospholipase D signaling pathway 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 80 | PI3K-Akt signaling pathway 3 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 81 | Platelet activation 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS1 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 82 | Propanoate metabolism 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ABAT |
D00535 |
Vigabatrin |
[2] 145, 158 |
| 83 | Prostate cancer 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 84 | Proteoglycans in cancer 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 85 | Rap1 signaling pathway 1 gene, 1 drug (DrugBank), 14 diseases shown |
[1] CNR1 |
D10915 |
Cannabidiol |
[14] 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
| 86 | Regulation of lipolysis in adipocytes 5 genes, 2 drugs (DrugBank), 14 diseases shown |
[3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| [2] PTGS1, PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 87 | Renin secretion 8 genes, 2 drugs (DrugBank), 34 diseases shown |
[3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 88 | Retrograde endocannabinoid signaling 2 genes, 2 drugs (DrugBank), 21 diseases shown |
[1] CNR1 |
D10915 |
Cannabidiol |
[14] 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
| [1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 89 | Salivary secretion 4 genes, 2 drugs (DrugBank), 5 diseases shown |
[3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| [1] SLC12A2 |
D00247 |
Bumetanide |
[2] 6, 158 |
| 90 | Serotonergic synapse 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] PTGS1, PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 91 | Shigellosis 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 92 | Small cell lung cancer 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 93 | T cell receptor signaling pathway 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 94 | Terpenoid backbone biosynthesis 1 gene, 1 drug (DrugBank), 19 diseases shown |
[1] HMGCR |
D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| 95 | Th1 and Th2 cell differentiation 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 96 | Th17 cell differentiation 6 genes, 3 drugs (DrugBank), 49 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 97 | Thermogenesis 5 genes, 5 drugs (DrugBank), 56 diseases shown |
[1] ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| [1] CNR1 |
D10915 |
Cannabidiol |
[14] 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 98 | Thyroid hormone signaling pathway 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 99 | Tight junction 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 100 | TNF signaling pathway 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 101 | Tuberculosis 6 genes, 2 drugs (DrugBank), 33 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] VDR |
D00129 |
Calcitriol |
[8] 37, 46, 49, 66, 96, 158, 235, 326 |
| 102 | Type II diabetes mellitus 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 103 | Valine, leucine and isoleucine degradation 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ABAT |
D00535 |
Vigabatrin |
[2] 145, 158 |
| 104 | VEGF signaling pathway 6 genes, 2 drugs (DrugBank), 33 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 105 | Vibrio cholerae infection 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SLC12A2 |
D00247 |
Bumetanide |
[2] 6, 158 |
| 106 | Wnt signaling pathway 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |